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INTRODUCTION
Cystic hypersecretory carcinoma (CHC) and cystic hyper-
secretory hyperplasia (CHH) were first described in 1984 (1).
The characteristic features of these lesions are dilated ducts
and cysts containing an eosinophilic secretory product resem-
bling thyroid colloid. After the initial report of CHC and
CHH, the entire spectrum of cystic hypersecretory lesions of
the breast was described by Guerry et al. in 1988 (2). These
lesions range from benign CHH to the intermediate CHH
with atypia and the frankly malignant CHC.
There have been only seven cases of invasive CHC report-
ed in the literature (1-5). We describe an additional case of
invasive CHC in a 45-yr-old female.
CASE REPORT
A 45-yr-old woman was admitted to the hospital for diag-
nosis and treatment of a palpable mass in the lower quadrant
of the left breast. The mass was soft and focally hard. She had
no past or family history of a breast disease. The sonograph
showed a cystic and lobulated mass. An excisional biopsy of
the left breast was performed. Gross pathologic examination
of the excisied specimen revealed an ill-defined, mucoid mass.
The cut surface of the mass, which was 4.7×3.7×3 cm,
revealed multiple cystic spaces, and the cysts were filled with
thick, gelatinous secretions. The individual cysts varied from
0.1 cm to 1.2 cm in dimension (Fig. 1). Intervening solid
areas were also noted. Microscopically, many cystically dilated
ducts contained thyroid colloid-like eosinophilic secretions.
The homogeneous secretions were retracted from the sur-
rounding epithelia, producing scalloped margins (Fig. 2A).
The secretory material also showed linear cracking artifact.
The cyst-lining epithelium exhibited variable patterns. The
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Invasive Cystic Hypersecretory Carcinoma of the Breast
: A Case Report
Cystic hypersecretory lesions of the breast are rare. These breast lesions include
cystic hypersecretory hyperplasia (CHH), atypical CHH, and cystic hypersecretory
carcinoma (CHC). The characteristic features are dilated ducts and cysts filled with
thyroid colloid-like eosinophilic secretion. Only seven cases of invasive CHC have
been reported in the literature. Here, we report an additional case of invasive CHC.
The histologic features of the tumor showed both micropapillary intraductal carcino-
ma and focal high-grade invasive carcinoma in a background of CHH. This case sug-
gests that cystic hypersecretory breast lesions encompass a spectrum of patholog-
ic lesions including CHH, atypical CHH, CHC, and invasive CHC.
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Fig. 1. The cut surface of the mass shows numerous cysts, mea-
suring up to 1.2 cm in diameter, with a gelatinous secretion.150 J.S. Lee, Y.J. Lee
lining of the cysts in most areas was of flat or cuboidal epithe-
lium and devoid of cellular atypia (Fig. 2B). The epithelium
of some cysts showed proliferative change ranging from atypi-
cal hyperplasia to intraductal carcinoma, micropapillary type
(Fig. 2C). The intraductal carcinoma component was accom-
panied by an invasive component with small solid nests (Fig.
2D). The invasive component was a high-grade carcinoma
lacking cystic and papillary traits. Histochemical staining of
the secretory material in the cysts was positive with periodic
acid-Schiff (PAS) and alcian blue. Immunohistochemically,
the cystic contents were positive for carcinoembryonic antigen
(CEA) (Zymed, San Franciscoa, CA, U.S.A., predilute), but
negative for thyroglobulin (Zymed, predilute). Immunostains
for estrogen and progesterone receptors (DAKO, Glostrup,
Denmark, predilute) and p53 protein (DAKO, dilution 1:100)
were negative in the neoplastic epithelial cells.
The diagnosis was invasive CHC. Modified radical mastec-
tomy with axillary lymph node dissection was performed.
Axillary lymph nodes were free of tumor metastasis. Subse-
quent radiotherapy was performed. The seven-month follow-
up period was uneventful.
Fig. 2. Microscopic findings. The lesion is composed of multiple cysts and ducts containing eosinophilic secretion (A, H&E, ×20). Most
of the cysts are lined by flat epithelium. The secretion retracts from the surrounding epithelium (B, H&E, ×200). The epithelium of some
cysts grows as micropapillary intraductal carcinoma (C, H&E, ×200). An invasive component (arrow) is found adjacent to the intraductal
carcinoma component (D, H&E, ×100).
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DISCUSSION
Cystic hypersecretory lesions of the breast have a spectrum
of morphologic features ranging from the clearly benign
(CHH), a combination of benign and atypical epithelium
(CHH with atypia), to cases that combine benign, atypical,
and frankly malignant epithelium (CHC) (2). The characteris-
tic gross features are the formation of dilated ducts and cysts
filled with a colloid-like secretion. Although cystic hypersecre-
tory lesions have a distinctive gross appearance, it is usually
not possible to distinguish CHC from CHH grossly. CHC
is differentiated from CHH by a micropapillary cyst lining
with cytologic atypia. If no cytologic atypia is present and
the epithelium is flat or cuboidal, the lesion is characterized
as CHH. Invasion is heralded by solid nests of invasive carci-
noma and is usually poorly differentiated with no secretory
characteristics. As a consequence, total excisional biopsy is
required for definitive diagnosis of cystic hypersecretory lesions
of the breast. 
About 50 cases of cystic hypersecretory breast lesions have
been reported (1-7). Most cases of CHC have been intraduc-
tal and only seven cases of invasive CHC have been reported
(1-5). Most invasive carcinomas have been poorly differentiated
duct carcinomas with a solid growth pattern. Invasive CHC
tends to have an aggressive behavior. Four cases were diagnosed
with lymph node metastases (2, 5). Metastatic foci in the axil-
lary lymph nodes had cystic foci that contained eosinophilic
secretion. One patient developed invasive lobular carcinoma
of the contralateral breast 10 yr after ipsilateral mastectomy
for invasive CHC (3). The patient described herein had neg-
ative lymph nodes. 
The present case is the eighth case of invasive CHC. In this
case all features of CHH were identified. In addition, micro-
papillary intraductal CHC and focal high-grade invasive car-
cinoma were also observed. Our case supports the concept that
cystic hypersecretory breast lesions encompass a spectrum of
pathologic lesions including CHH, atypical CHH, CHC, and
invasive CHC. The progression of these lesions from CHH,
through intraductal CHC, to invasive CHC may be possible.
The differential diagnosis of invasive CHC includes secreto-
ry carcinoma, mucinous carcinoma, malignant mucocele-like
tumor, and metastatic thyroid carcinoma. Secretory carcino-
ma contains vacuolated cytoplasm and more bubbly secre-
tions, which are not typical features of CHC (8). Mucinous
carcinoma and malignant mucocele-like tumor also show
cystically dilated ducts (9). However, the secretions in these
lesions are rather pale and basophilic and do not show linear
cracking artifacts. Metastatic follicular thyroid carcinoma of
the breast may mimic CHC. Histologic differentiation of
these two conditions may require immunohistochemical stain
for thyroglobulin. Negative reaction for thyroglobulin was
observed in the cyst contents of our case.
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